至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.
A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding
Cell Res .2022-09;
Yingdan Wang # 1, Wuqiang Zhan # 1, Jiangyan Liu # 1 2, Yanqun Wang # 3, Xiang Zhang 1, Meng Zhang 1, Lin Han 1, Yunping Ma 1, Lu Lu 1, Yumei Wen 1, Zhenguo Chen 1, Jincun Zhao 4 5, Fan Wu 6, Lei Sun 7, Jinghe Huang 8
